Obstructive sleep apnea and the risk of chronic kidney disease – glomerular filtration rate estimations based on serum cystatin C and creatinine concentrations

Adam Nowinski (Warsaw, Poland), Adam Nowinski, Anna Czyzak-Gradkowska, Damian Korzybski, Luiza Jonczak, Przemyslaw Bielen, Robert Plywaczewski, Pawel Sliwinski

Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Session: Inflammation, biomarkers and hypoxia in sleep disordered breathing
Session type: Thematic Poster Session
Number: 2329
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Adam Nowinski (Warsaw, Poland), Adam Nowinski, Anna Czyzak-Gradkowska, Damian Korzybski, Luiza Jonczak, Przemyslaw Bielen, Robert Plywaczewski, Pawel Sliwinski. Obstructive sleep apnea and the risk of chronic kidney disease – glomerular filtration rate estimations based on serum cystatin C and creatinine concentrations. Eur Respir J 2015; 46: Suppl. 59, 2329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Estimated glomerular filtration rate (eGFR) changes after obstructive sleep apnea (OSA) treatment by positive airway pressure: data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – CPAP therapy
Year: 2017


The concentration and expression of L-selectin in normoglycemic obstructive sleep apnea patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Urine albumin excretion (UAE) is predictive of subclinical cardiovascular diseases associated with obstructive sleep apnea syndrome (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2)
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013

Long term changes of C-rective protein (CRP) in obstructive sleep apnoea (OSA) with or without treatment
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016


Association between 25-hydroxyvitamin D and interleukin 17 levels in severe obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Serum vitamin D levels are associated with markers of hypoxia in obstructive sleep apnea patients
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013

Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Association between plasma haemoglobin A1c (HbA1c) concentration and overnight desaturation in obstructive sleep apnoea (OSA) patients without diabetes
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013


Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


Multimorbidity is a risk factor for obstructive sleep apnea-hypopnea syndrome in ageing
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Pharyngeal and systemic inflammation in obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Heart rate variability, nocturnal hypoxemia and C-reactive protein in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


OSA complication score as novel reference to assess systemic inflammation in sleep apnoea
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015

Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010

Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007